[Experience in the use of ditrastic in the therapy of psoriasis].
Forty-six patients suffering from psoriasis have been treated with ditrastic, a new drug for external application, manufactured by Orion, Finland. The drug is manufactured in the form of sticks weighing 2.4 g, containing 1.5 or 3% of dithranol, paraffin, and microcrystalline sulfur. These sticks are applied to psoriatic plaques once daily. The treatment has been effective.
Shakhtmeĭster
I Ia
IIa
Kaukhova
O Ia
OIa
Kunin
N A
NA
Shablinskaia
E M
EM
Kozyreva
L G
LG
D000293:Adolescent; D000328:Adult; D000875:Anthralin / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010232:Paraffin / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D013455:Sulfur / Q000627:therapeutic use*
D004338:Drug Combinations; C059206:ditrastic; D013455:Sulfur; D010232:Paraffin; D000875:Anthralin
Opyt primeneniia ditrastika v terapii psoriaza.